Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

CJC-1295 Draw Technique: Syringe Type Comparison

Insulin syringe (0.5mL) 28–30G 0.01–0.02mL Doses ≤0.5mL, minimises waste Low. Single-use design Optimal for most CJC-1295 protocols; dead space negligible for research dosing Insulin syringe (1mL) 27–29G 0.02–0.03mL Doses 0.5–1.0mL Preferred for higher-volume

This comparison does not assign a generated winner or score.

  • Insulin syringe (0.5mL)
  • 28–30G
  • 0.01–0.02mL
  • Doses ≤0.5mL, minimises waste
  • Low. Single-use design
  • Optimal for most CJC-1295 protocols; dead space negligible for research dosing
  • Insulin syringe (1mL)
  • 27–29G
  • 0.02–0.03mL
  • Doses 0.5–1.0mL
  • Preferred for higher-volume draws; slightly larger dead space acceptable
  • Luer-lock syringe + separate needle
  • 25–27G
  • 0.05–0.10mL
  • Multi-vial sampling, larger volumes
  • Moderate. Connection point adds contamination risk
  • Avoid for single-vial peptide use; dead space wastes expensive compound
  • Prefilled syringe (some research kits)
  • Fixed 27G
  • 0.00mL
  • Pre-measured doses only
  • Very low. Sealed until use
  • Eliminates user error but limits dosing flexibility
More references

Related material